GUIA DE ACTUACION EN URGENCIAS EN EL CENTRO DE SALUD RURAL by OMC. España

GUIA DE ACTUACION EN URGENCIAS EN EL CENTRO DE SALUD RURAL by OMC. España

Bajar PDF Gratis AQUI

EMS Group Latin America code QR TELEGRAM 
https://t.me/joinchat/GRsTvEHYjNLP8yc6gPXQ9Q

AED Automatic External Defibrillator . UN compacto, economico y seguro https://emssolutionsint.blogspot.com/2019/08/aed-automatic-external-defibrillator-un.html

DESCARGA MANUAL PDF en Español 

Dr. RAMON REYES, MD, DMO, EMT-T 

Medical Doctor for complex and high-risk missions

eeiispain@gmail.com

        

“Medicina Bona Locis Malis”

EU Medical Doctor / Spain 

Advanced Prehospital Trauma Life Support /Tactical Combat Casualty Care TCCC Instructor and Faculty 

ACLS EP / PALS American Heart Association and European Resucitation Council Instructor and Faculty

Member SOMA Special Operational Medical Association 

Corresponding Member Dominican College of Surgeons 

Member European Society of Emengency Medicine 

Board of International EMS Registry

DMO Diving Medical Officer- USA

Air Medical Crew Instructor DOT- USA

Tactical Medical Specialist and Protective Medicine -USA

TECC Tactical Emergency Casualty Care Faculty and Medical Director by C-TECC

My LinkedIn 

My Blog EMS SOLUTIONS INTERNATIONAL

https://www.eeti.training/    

Intervenciones de #enfermería para la atención de la mujer con herida quirúrgica infectada post-cesarea en los tres niveles de atención PDF Gratis

Intervenciones de #enfermería para la atención de la mujer con herida quirúrgica infectada post-cesarea en los tres niveles de atención PDF Gratis

DESCARGAR 

#EnfermeríaQuirúrgica

EMS Group Latin America code QR TELEGRAM 
https://t.me/joinchat/GRsTvEHYjNLP8yc6gPXQ9Q

SICH STRENGTHENED INDIVIDUAL COMBAT HYBRID TOURNIQUET

https://emssolutionsint.blogspot.com/2019/01/tq-tourniquet-sich-strengthened.html

AED Automatic External Defibrillator . UN compacto, economico y seguro https://emssolutionsint.blogspot.com/2019/08/aed-automatic-external-defibrillator-un.html

DESCARGA MANUAL PDF en Español 

Dr. RAMON REYES, MD, DMO, EMT-T 

Medical Doctor for complex and high-risk missions

eeiispain@gmail.com

        

“Medicina Bona Locis Malis”

EU Medical Doctor / Spain 

Advanced Prehospital Trauma Life Support /Tactical Combat Casualty Care TCCC Instructor and Faculty 

ACLS EP / PALS American Heart Association and European Resucitation Council Instructor and Faculty

Member SOMA Special Operational Medical Association 

Corresponding Member Dominican College of Surgeons 

Member European Society of Emengency Medicine 

Board of International EMS Registry

DMO Diving Medical Officer- USA

Air Medical Crew Instructor DOT- USA

Tactical Medical Specialist and Protective Medicine -USA

TECC Tactical Emergency Casualty Care Faculty and Medical Director by C-TECC

My LinkedIn 

My Blog EMS SOLUTIONS INTERNATIONAL

https://www.eeti.training/    

Interim Guidance on Outbreak of 2019 Novel Coronavirus 2019-nCoV by CDC

Distributed via the CDC Health Alert Network
February 1, 2020, 0900 ET (9:00 AM ET)
CDCHAN-00427

Summary
The Centers for Disease Control and Prevention (CDC) continues to closely monitor an outbreak of respiratory illness caused by a novel coronavirus (2019-nCoV) that was initially detected in Wuhan City, Hubei Province, China in December 2019.

This CDC Health Alert Network (HAN) Update provides a situational update and interim guidance to state and local health departments that supersedes guidance in CDC’s HAN 426 distributed on January 17, 2020. It also adds

• guidance for clinicians caring for patients with 2019-nCoV (https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html),
• and for public health officials on the evaluation and testing of patients under investigation (PUIs) for 2019-nCoV (https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html), and
• updated infection prevention and control guidance specific to 2019-nCoV (https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html).

Early in the outbreak, many of the patients with respiratory illness caused by 2019-nCoV in China had exposure to a large seafood and live animal market, suggesting animal-to-human transmission. More recently, cases have been confirmed with no exposure to animal markets, indicating that person-to-person spread of the virus has occurred. Chinese officials report that sustained person-to-person spread in the community is occurring in China.

The first US case-patient was identified on January 21, 2020, and had recently traveled from Wuhan, China. Since that time, six additional cases have been confirmed in the United States, four among persons who traveled from Wuhan, and one a close contact of a confirmed case. Globally, reported illnesses in people with 2019-nCoV have ranged from mild (no or few signs and symptoms), to severe, including death. These findings are consistent with other coronaviruses, including Severe Acute Respiratory Syndrome (SARS) (https://www.cdc.gov/sars/) and Middle East Respiratory Syndrome (MERS) (https://www.cdc.gov/coronavirus/mers/index.html). Additional information about 2019-nCoV is needed to better understand transmission, disease severity, and risk to the general population. The goal of the ongoing US public health response is to identify and contain this outbreak and prevent sustained spread of 2019-nCoV in the United States.

Recommendations for Screening of Patients for 2019-nCoV in Healthcare Facilities
Recommendations for screening of patients for possible 2019-nCoV infection are based on (1) current knowledge of the characteristics of clinical illness observed in early cases, and (2) the geographic distribution of current cases. They reflect the current public health goal of rapidly containing and preventing transmission of 2019-nCoV illness.

Patients presenting to healthcare facilities should be assessed for exposures associated with risk of 2019-nCoV infections (e.g., travel to China or close contact with a confirmed case) and for symptoms consistent with 2019-nCoV infection (https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html). The assessment is intended to allow healthcare providers to make decisions about appropriate infection control and management of patients.  Note that the signs and symptoms of 2019-nCoV overlap with those associated with other viral respiratory tract infections. Given the time of year, common respiratory illnesses, including influenza, should also be considered in patients who are screened. (Figure 1)

Clinicians should ask:

• Does the person have fever or symptoms of lower respiratory infection, such as cough or shortness of breath?

AND

• Has the patient traveled to mainland China within 14 days of symptom onset?

OR

• Has the patient had close contact1 with a person confirmed with 2019-nCoV infection?

If a patient meets these criteria:

• To minimize the risk that other people will be exposed to individuals who may have 2019-nCoV, patients who report having these symptoms should be asked to wear a surgical mask as soon as they are identified and directed to a separate area, if possible, with at least 6 feet (2 meters) separation from other persons. Patients should be evaluated in a private room with the door closed, ideally an airborne infection isolation room (AIIR), if available. Healthcare personnel entering the room should use standard precautions, contact precautions, airborne precautions, and use eye protection (e.g., goggles or a face shield). For more information about this, see CDC’s Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting (https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html).

Clinicians should immediately notify the healthcare facility’s infection control personnel and local health department. The health department will determine if this patient needs to be considered a PUI for 2019-nCoV and be tested for infection.

Criteria to Guide Evaluation and Testing of Patients Under Investigation (PUI) for 2019-nCoV
Local health departments, in consultation with clinicians, should determine whether a patient is a PUI for 2019-nCoV. The CDC clinical criteria for 2019-nCoV PUIs have been developed based on available information about this novel virus, as well as what is known about SARS and MERS. These criteria are subject to change as additional information becomes available.

Clinical Features	AND	Epidemiologic Risk
Fever2 or signs/symptoms of lower respiratory illness (e.g. cough or shortness of breath)	AND	Any person, including health care workers, who has had close contact1 with a laboratory-confirmed3 2019-nCoV patient within 14 days of symptom onset
Fever2 and signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath)	AND	A history of travel from Hubei Province, China within 14 days of symptom onset
Fever2 and signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath) requiring hospitalization4	AND	A history of travel from mainland China within 14 days of symptom onset

These criteria are intended to serve as guidance for evaluation and testing. Patients should be evaluated and discussed with public health departments on a case-by-case basis for possible 2019-nCoV infection.  Testing decisions might be further informed by the clinical presentation or exposure history (e.g., uncertain travel or exposure), and the presence of an alternative diagnosis that explains their clinical presentation.

Recommendations for Reporting, Testing, and Specimen Collection
Healthcare providers should immediately notify infection control personnel at their healthcare facility if a patient is classified a PUI for 2019-nCoV. State health departments that have identified a PUI should immediately contact CDC’s Emergency Operations Center (EOC) at 770-488-7100 and complete a 2019-nCoV PUI case investigation form (https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html#reporting-testing-specimen-collection). CDC’s EOC will assist local and state health departments with obtaining, storing, and shipping appropriate specimens to CDC, including afterhours or on weekends or holidays. Currently, diagnostic testing for 2019-nCoV can be done only at CDC. Testing for other respiratory pathogens should not delay specimen shipping to CDC.

For initial diagnostic testing for 2019-nCoV, CDC recommends collecting and testing upper respiratory (nasopharyngeal AND oropharyngeal swabs), and lower respiratory (sputum, if possible)) for those patients with productive coughs. Induction of sputum is not indicated. Specimens should be collected as soon as possible once a PUI is identified, regardless of the time of symptom onset. See Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV) (https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html).

Recommendations for Healthcare Providers
No vaccine or specific treatment for 2019-nCoV infection is available. At present, medical care for patients with 2019-nCoV is supportive.

Persons with confirmed or suspected 2019-nCoV infection who are hospitalized should be evaluated and cared for in a private room with the door closed, ideally an airborne infection isolation room, if available. For more information, see Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting (https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html).

Home care and isolation may be an option, based on clinical and public health assessment, for some persons. Please see Interim Guidance for Preventing the Spread of 2019 Novel Coronavirus (2019-nCoV) in Homes and Communities (https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html).

Those isolated at home should be monitored by public health officials to the extent possible. Refer to Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (2019-nCoV) (https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html) for more information.

Notes
1Close contact is defined as:
a) being within approximately 6 feet (2 meters), or within the room or care area, of a 2019-nCoV case for a prolonged period of time while not wearing recommended personal protective equipment or PPE (e.g., gowns, gloves, NIOSH-certified disposable N95 respirator, eye protection); close contact can include caring for, living with, visiting, or sharing a health care waiting area or room with a 2019-nCoV case
– or –
b) having direct contact with infectious secretions of a 2019-nCoV case (e.g., being coughed on) while not wearing recommended personal protective equipment.
2Fever may be subjective or confirmed

See CDC’s updated Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting (https://www.cdc.gov/coronavirus/2019-ncov/infection-control.html).

Data to inform the definition of close contact are limited. Considerations when assessing close contact include the duration of exposure (e.g., longer exposure time likely increases exposure risk) and the clinical symptoms of the person with 2019-nCoV (e.g., coughing likely increases exposure risk as does exposure to a severely ill patient). Special consideration should be given to those exposed in health care settings.
3 Documentation of laboratory-confirmation of 2019-nCoV may not be possible for travelers or persons caring for patients in other countries.
4 Category also includes any member of a cluster of patients with severe acute lower respiratory illness (e.g., pneumonia, ARDS) of unknown etiology in which 2019-nCoV is being considered that requires hospitalization. Such persons should be evaluated in consultation with state and local health departments regardless of travel history.

For More Information
More information is available at the 2019 Novel Coronavirus website (https://www.cdc.gov/coronavirus/2019-ncov/index.html) or by
calling 800-CDC-INFO | (800-232-4636) | TTY: (888) 232-6348

The Centers for Disease Control and Prevention (CDC) protects people’s health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national and international organizations.

DEPARTMENT OF HEALTH AND HUMAN SERVICES

HAN Message Types

• Health Alert: Conveys the highest level of importance; warrants immediate action or attention.
• Health Advisory: Provides important information for a specific incident or situation; may not require immediate action.
• Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action.
• Info Service: Provides general information that is not necessarily considered to be of an emergent nature.

###
This message was distributed to state and local health officers, state and local epidemiologists, state and local laboratory directors, public information officers, HAN coordinators, and clinician organizations.
###

Este Blog va dirigido a profesionales de la salud y publico en general EMS Solutions International garantiza, en la medida en que puede hacerlo, que los contenidos recomendados y comentados en el portal, lo son por profesionales de la salud. Del mismo modo, los comentarios y valoraciones que cada elemento de información recibe por el resto de usuarios registrados –profesionales y no profesionales-, garantiza la idoneidad y pertinencia de cada contenido.

Es pues, la propia comunidad de usuarios quien certifica la fiabilidad de cada uno de los elementos de información, a través de una tarea continua de refinamiento y valoración por parte de los usuarios.

Si usted encuentra información que considera erronea, le invitamos a hacer efectivo su registro para poder avisar al resto de usuarios y contribuir a la mejora de dicha información.

El objetivo del proyecto es proporcionar información sanitaria de calidad a los individuos, de forma que dicha educación repercuta positivamente en su estado de salud y el de su entorno. De ningún modo los contenidos recomendados en EMS Solutions International están destinados a reemplazar una consulta reglada con un profesional de la salud.

Pueblo más cardioprotegido de España

Jimera de Libar (Málaga) se convierte en el pueblo más cardioprotegido de España

Con un desfibrilador por cada 92 habitantes, el municipio malagueño de Jimera de Libar, situado en la comarca de la Serranía de Ronda, se ha convertido en la localidad española más cardioprotegida. En España, la media es de un desfibrilador por cada 2.000 personas.

El municipio cuenta un total de 5 desfibriladores de uso público, distribuidos por la localidad, y muchos de sus ciudadanos ha recibido formación en el uso de estos equipos y en técnicas de reanimación cardiopulmonar (RCP) y soporte vital avanzado (SVA) para que puedan actuar correctamente y con eficacia ante cualquier emergencia cardíaca.

El alcalde de la localidad, Francisco Lobos, tomó la decisión de cardioproteger el pueblo, a sus vecino y visitantes, tras conocer que en la Calle Larios de Málaga se habían instalado desfibliladores iniciativa tras conocer la noticia de la instalación de desfibriladores en la Calle Larios de Málaga. El proyecto comenzó con la instalación de un primer desfiblilador, que contó con el apoyo de la Diputación malagueña y recientemente se han instalado otros cuatro equipos. “Los vecinos están encantados porque se sienten más seguros y otro tanto ocurre con los miles de visitantes que recibimos cada año”, comenta el alcalde.

Dos de los desfibriladores están ubicados en las dos plazas del pueblo más concurridas: la Plaza Virgen de la Salud y la Plaza de San Roque. Ésta última instalación cuenta con desfibriladores DOC de B+SAFE, los mñás avanzados del mercado, que proporcionan al usuario tele-aistencia 24 horas por parte de un especialista en emergencias, llamada al 061 y geolocalización con la ubicación del desfibrilador. También cuentan con sistema de telecontrol permanente y tele mantenimiento que garantizan su buen funcionamiento.

Los nuevos equipos se presentarán oficialmente el próximo jueves, día en el que la cardioprotección será la gran protagonista de Jimera de Libar.

“Queremos concienciar y enseñar a la población a saber actuar ante una emergencia cardíaca. Que sepan dónde hay un desfibrilador disponible en Jimera de Libar y cómo usarlo”, explica su alcalde Francisco Lobos.

La ciudad de Málaga es otro gran ejemplo en el avance de la cardioprotección en España. Actualmente cuenta con un 1 desfibrilador por cada 1900 habitantes, con la reciente ampliación de 50 nuevos desfibriladores extra. Un ejemplo al que se han unido municipios como Jimera de Libar.

Compartir CompartirGuardar

Campaña 'EN URGENCIAS LA SEGURIDAD DEL PACIENTE ESTA EN NUESTRAS MANOS'

'"En Urgencias, la Seguridad del Paciente está en nuestras manos", campaña diseñada por la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES) y Fundación Mapfre, con la colaboración de los Ministerios de Sanidad, Servicios Sociales e Igualdad y el Ministerio de Defensa en su rama sanitaria. Es una campaña dirigida a los profesionales sanitarios, con el objetivo de reducir los riesgos derivados de la asistencia sanitaria urgente y mejorar la Seguridad del Paciente. Con este proyecto, FUNDACIÓN MAPFRE y SEMES pretenden sensibilizar, a los profesionales del sector sanitario encargados de la atención urgente acerca de la importancia de la prevención de los riesgos en su ámbito, garantizando la mejora de la seguridad del paciente. Para alcanzar este objetivo la Fundación, que desde hace más de 15 años trabaja en el área de Seguridad del Paciente, junto con SEMES promoverán distintas acciones divulgativas en servicios de urgencias y emergencias, hospitales, centros de atención primaria, facultades así como a los propios profesionales, entre otros, difundiendo material de carácter formativo, tanto impreso como audiovisual, sobre esta materia. ¿Por qué es necesario? Los servicios de urgencias constituyen una de las áreas asistenciales donde existe mayor riesgo de eventos adversos; las apariciones de los mismos se ve favorecida por diferentes características: alto número de pacientes, diversa complejidad clínica de sus patologías, así como las particularidades laborales, profesionales y organizativas de estos Servicios, que ayudan a que exista un elevado riesgo de problemas de seguridad. manos_imagen1En concreto, en nuestro país, el estudio EVADUR (Eventos Adversos ligados a la asistencia en los servicios de Urgencias españoles) ha situado en al menos un 12% la incidencia de pacientes visitados en urgencias que sufren algún tipo de incidente relacionados con la asistencia sanitaria, de los que, aproximadamente, un 70% pueden ser evitables. Mejorar la seguridad del paciente es un objetivo prioritario tanto para los profesionales sanitarios como para las organizaciones que trabajan en esta área. Cabe destacar que la campaña se centra en la difusión de 10 recomendaciones a seguir por los profesionales para evitar eventos adversos a los pacientes durante la asistencia urgente, relacionados con los riesgos sanitarios más frecuentes detectados en Urgencias, de acuerdo con la bibliografía y con los estudios realizados tanto por SEMES como por FUNDACION MAPFRE. Objetivos Sensibilizar a los profesionales sobre la importancia de adoptar medidas preventivas que puedan reducir el índice de eventos adversos en las personas atendidas, en los servicios de Urgencias en particular, y en el ámbito sanitario en general. Comprometer a las organizaciones y los profesionales de urgencias con la mejora de la Seguridad del Paciente. Promover prácticas clínicas seguras. Proporcionar un material actualizado y práctico que ayude a los profesionales a reducir los riesgos durante la asistencia que prestan a los pacientes

Descargar archivos adjuntos: Poster de recomendaciones (502 Descargas) Tríptico (479 Descargas)